Minaris Launches AgentSCREEN Adventitious Virus Detection by NGS to Simplify Viral Safety Testing for Cell Banks and Cell-Based Samples

Minaris, a global cell and gene therapy (CGT) contract development and manufacturing organization (CDMO) and multimodality biosafety testing provider, today announced the launch of AgentSCREEN ...
Managed Healthcare Executive

NGS-based detection of circulating HPV DNA offers promise for monitoring for early recurrence of cervical cancer

A custom NGS panel covering 27 IARC carcinogenic HPV genotypes enabled detection of ccfHPV DNA across treatment strata and ...

Next Generation Sequencing Market Competitive Landscape Report 2025 Featuring Top Players - Thermo Fisher Scientific, Pacific Biosciences, Illumina, Roche

Generation Sequencing (NGS) market is set to surge from $14.79 billion in 2025 to $56.25 billion by 2033, with a robust CAGR of 18.17%. Key drivers include advancements in sequencing technologies, ...
MarketWatch

Next Generation Sequencing (NGS) Market Poised to Hit $42.25 Billion by 2033: Key Drivers Behind the Surge - Latest Study by Grand View Research, Inc.

SAN FRANCISCO, Nov. 13, 2025 /PRNewswire/ -- The global next-generation sequencing market size is anticipated to reach USD 42.25 billion by 2033, growing at a CAGR of 18.0% from 2025 to 2033. The next ...

Gilson Launches Application-Configured PIPETMAX(R) Systems for qPCR, NGS, and Bioassays

Gilson has announced the release of its new application-configured PIPETMAX(R) systems, offering turnkey automation for qPCR, next-generation sequencing (NGS), and plate-based bioassays. Built around ...

Devyser Diagnostics AB: Devyser launches the first IVDR compliant NGS assay for thalassemia and sickle cell disease testing

Devyser, today announced the launch of Devyser Thalassemia v2, the first Next-Generation Sequencing (NGS) assay for genetic analysis of thalassemia and sickle cell disease (SCD) available on the Europ ...
ascopubs.org

Next generation sequencing (NGS) of malignant effusions and comparison to blood liquid biopsy (ctDNA): A community experience.

Pattern of resistance on first-line EGFR-directed therapy in EGFR-positive metastatic non-small cell lung cancer. Utilizing TP53 mutation status and initial disease burden at presentation to ...
Pharmabiz

Ultima Genomics, Hamilton partner to enable improved lab operations to drive sequencing at scale

Ultima Genomics, Hamilton partner to enable improved lab operations to drive sequencing at scale: Fremont, California Saturday, February 28, 2026, 11:00 Hrs [IST] Ultima Genomics, ...
Express Healthcare

Bio Valley, 4baseCare and Define Bio sign MoU to set up genomics CoE at AMTZ Vizag

Hitesh Goswami, CEO and Co-founder of 4baseCare, said, “This collaboration with Bio Valley, 4baseCare and Define Bio represents a significant step in strengthening India’s innovation-led Biotech ...
ascopubs.org

HER2 Protein Overexpression, mRNA Expression, and DNA Amplification Across Solid Tumors: Comparison of Next-Generation Sequencing–Based Assays With Immunohistochemistry

Real-World Plasma Thymidine Kinase Activity in High-Risk and Metastatic Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer Treated With Cyclin-Dependent Kinase ...